z-logo
open-access-imgOpen Access
Novel insights into the molecular mechanisms governing Mdm2 ubiquitination and destruction.
Author(s) -
Hiroyuki Inuzuka,
Hidefumi Fukushima,
Shavali Shaik,
Wenyi Wei
Publication year - 2010
Publication title -
pubmed
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.373
H-Index - 127
eISSN - 1949-2553
DOI - 10.18632/oncotarget.101011
Subject(s) - mdm2 , ubiquitin ligase , ubiquitin , phosphorylation , microbiology and biotechnology , kinase , cancer research , casein kinase 2 , biology , medicine , genetics , protein kinase a , cell culture , cyclin dependent kinase 2 , gene
The Mdm2/p53 pathway is compromised in more than 50% of all human cancers, therefore it is an intensive area of research to understand the upstream regulatory pathways governing Mdm2/p53 activity. Mdm2 is frequently overexpressed in human cancers while the molecular mechanisms underlying the timely destruction of Mdm2 remain unclear. We recently reported that Casein Kinase I phosphorylates Mdm2 at multiple sites to trigger Mdm2 interaction with, and subsequent ubiquitination and destruction by the SCF(β-TRCP) E3 ubiquitin ligase. We also demonstrated that the E3 ligase activity-deficient Mdm2 was still unstable in the G1 phase and could be efficiently degraded by SCF(β-TRCP). Thus our finding expands the current knowledge on how Mdm2 is tightly regulated by both self- and SCF(β-TRCP)-dependent ubiquitination to control p53 activity in response to stress. It further indicates that loss of β-TRCP or Casein Kinase I function contributes to elevated Mdm2 expression that is frequently found in various types of tumors.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here